| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/02/1999 | WO1999043350A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by adp-ribosylating exotoxin |
| 09/02/1999 | WO1999043349A1 Mucosal microparticle conjugate vaccine |
| 09/02/1999 | WO1999043348A1 Immunostimulation methods for providing disease protection in poultry |
| 09/02/1999 | WO1999043343A1 Novel peptide copolymer compositions |
| 09/02/1999 | WO1999043286A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | WO1999034015A3 Polymorphisms within the rsk-3 gene related to cancer and methods of diagnosis, prognosis, and treatment |
| 09/02/1999 | WO1999033488A3 Adjuvanted vaccine formulation |
| 09/02/1999 | WO1999027109A3 EXTRACELLULAR MATRIX-BINDING PROTEINS FROM $i(STAPHYLOCOCCUS AUREUS) |
| 09/02/1999 | WO1999020766A3 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 09/02/1999 | WO1999019357A9 Cell regulatory genes, encoded products, and uses related thereto |
| 09/02/1999 | WO1998034632A9 Compounds and compositions for delivering active agents |
| 09/02/1999 | WO1998030693A9 Tumor necrosis factor receptor 5 |
| 09/02/1999 | CA2792479A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2322175A1 Mucosal microparticle conjugate vaccine |
| 09/02/1999 | CA2322160A1 Vaccines, immunotherapeutics and methods for using the same |
| 09/02/1999 | CA2321974A1 Tumor associated antigen 791tgp72 |
| 09/02/1999 | CA2321947A1 High affinity humanized anti-cea monoclonal antibodies |
| 09/02/1999 | CA2321932A1 High affinity humanized anti-tag-72 monoclonal antibodies |
| 09/02/1999 | CA2321883A1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 09/02/1999 | CA2321870A1 Cell cycle related proteins |
| 09/02/1999 | CA2321869A1 Human proteinase molecules |
| 09/02/1999 | CA2321747A1 Human smn-like protein |
| 09/02/1999 | CA2321223A1 Hla linked pre-eclampsia and miscarriage susceptibility gene |
| 09/02/1999 | CA2320289A1 Novel peptide copolymer compositions |
| 09/01/1999 | EP0939131A2 Aminopeptidases |
| 09/01/1999 | EP0939128A2 New HCV isolates |
| 09/01/1999 | EP0939127A2 Humanized immunoglobulins and their production and use |
| 09/01/1999 | EP0939124A2 MGBP1 sequences |
| 09/01/1999 | EP0938565A2 Vaccine compositions |
| 09/01/1999 | EP0938563A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods |
| 09/01/1999 | EP0938561A1 Genes encoding mycobacterial proteins associated with cell binding and cell entry and uses thereof |
| 09/01/1999 | EP0938558A2 Gaba a receptor subunit epsilon-related protein |
| 09/01/1999 | EP0938557A2 Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammalian cd97 alpha subunit |
| 09/01/1999 | EP0938506A1 Immunoglobulin superfamily domains and fragments with increased solubility |
| 09/01/1999 | EP0938505A1 Anti-endoglin monoclonal antibodies and their use in antiangiogenic therapy |
| 09/01/1999 | EP0938498A1 Multivalent compounds for cross-linking receptors and uses thereof |
| 09/01/1999 | EP0938497A1 Constrained helical peptides and methods of making same |
| 09/01/1999 | EP0938337A1 Chimeric kanamycin resistance gene |
| 09/01/1999 | EP0938336A1 A method for enhancing long-term memory in a subject and uses thereof |
| 09/01/1999 | EP0938335A1 In ovo vaccination against newcastle disease |
| 09/01/1999 | EP0938334A1 Improved method of treating immune cell mediated systemic diseases |
| 09/01/1999 | EP0938329A1 Immunogenic tlp composition |
| 09/01/1999 | EP0938320A1 Method enabling use of extracellular rna extracted from plasma or serum to detect, monitor or evaluate cancer |
| 09/01/1999 | EP0938298A1 Liposomes |
| 09/01/1999 | EP0573545B1 Monoclonal antibodies against receptor-induced binding sites |
| 09/01/1999 | CN1227611A Isolated nucleic acid molecules which are members of the MAGE-B family and use thereof |
| 09/01/1999 | CN1227610A Antibodies against a complex of CD4 and a chemokine receptor domain, and their use against HIV infections |
| 09/01/1999 | CN1227607A Humanized immunoglobulin reactive with alpha 4 beta 7 integrin |
| 09/01/1999 | CN1227566A T cell epitope peptide |
| 09/01/1999 | CN1227565A Viral peptides with structural homology to protein G of respiratory syncytial virus |
| 09/01/1999 | CN1227497A Purified sperm surface antigen, monoclonal antibody therefor and application therefor |
| 09/01/1999 | CN1227496A Screening method for compounds useful in the regulation of body weight |
| 09/01/1999 | CN1227494A Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cell |
| 09/01/1999 | CN1044911C Method for preparing prodrug |
| 08/31/1999 | US5945513 A human t-cell antigen and ligand for cd40 receptor; for promoting b cell proliferation, immunosuppressant for transplants, therapy for autoimmune diseases, human immunodeficiency virus and antitumor agents |
| 08/31/1999 | US5945512 An antibody against amino-terminated peptide for the detection of diabetic vascular disorders |
| 08/31/1999 | US5945505 Human phospholemman-like protein |
| 08/31/1999 | US5945456 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| 08/31/1999 | US5945400 Nucleic acid-containing composition, preparation and use thereof |
| 08/31/1999 | US5945330 Polynucleotide |
| 08/31/1999 | US5945322 Several open reading frames from neisseria gonorrhoeae; for diagnosis and bactericides; for probes and primers |
| 08/31/1999 | US5945310 DNA encoding members of the IL-1 family, IL-1 delta |
| 08/31/1999 | US5945277 Determining the presence of four corners virus in a sample by reverse transcribing viral rna then amplifying the dna using primers, the detected amplified product indicates the presence of adult respiratory distess syndrome |
| 08/31/1999 | US5945115 Polymeric compositions useful as controlled release implants |
| 08/31/1999 | US5945105 Peptides of the antigen Sm-D and their use, in particular for the diagnostics of systemic lupus erythematosus (SLE) |
| 08/31/1999 | US5945104 A peptide carrier conjugate where carrier is selected from tetanus-texoid and purified protein derivative of tuberculin |
| 08/31/1999 | US5945098 Stable intravenously-administrable immune globulin preparation |
| 08/31/1999 | US5945096 Administering to the human for suppressing a human immune response to an antigen, an effective amount of antigen non-specific human glycosylation inhibiting factor |
| 08/26/1999 | WO1999042596A2 Phosphodiesterase 10 |
| 08/26/1999 | WO1999042593A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 08/26/1999 | WO1999042588A2 Group b streptococcus antigens |
| 08/26/1999 | WO1999042585A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 08/26/1999 | WO1999042584A1 Apoptosis inducing molecule ii and methods of use |
| 08/26/1999 | WO1999042579A2 Caf1-related protein |
| 08/26/1999 | WO1999042573A1 Immunological methods to modulate myostatin in vertebrate subjects |
| 08/26/1999 | WO1999042564A2 Apoptotic cell-mediated antigen presentation to dendritic cells |
| 08/26/1999 | WO1999042562A1 NOVEL pgsA |
| 08/26/1999 | WO1999042484A1 Fishboy, a g-protein coupled receptor |
| 08/26/1999 | WO1999042480A1 Analgesic peptides from venom of grammostola spatulata and use thereof |
| 08/26/1999 | WO1999042479A1 Novel peptide diagnostic reagent and kit for detection of rickettsiosis |
| 08/26/1999 | WO1999042478A2 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32 |
| 08/26/1999 | WO1999042477A2 Transporter protein for saccharide-coupled medicaments |
| 08/26/1999 | WO1999042472A1 Heat shock fusion-based vaccine system |
| 08/26/1999 | WO1999042133A1 Inhibitors of complement activation |
| 08/26/1999 | WO1999042131A1 Skin care compositions |
| 08/26/1999 | WO1999042130A1 Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| 08/26/1999 | WO1999042129A1 Purified sperm surface antigen, monoclonal antibody therefor and application therefor |
| 08/26/1999 | WO1999042128A1 Method for selecting tumours expressing hla-g, sensitive to anticancer treatment and uses |
| 08/26/1999 | WO1999042121A1 Modified heat shock protein-antigenic peptide complex |
| 08/26/1999 | WO1999042118A2 Compounds and methods for diagnosis of tuberculosis |
| 08/26/1999 | WO1999042076A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/26/1999 | WO1999042075A2 Antibodies against human cd40 |
| 08/26/1999 | WO1999031257A3 Protein expression in baculovirus vector expression systems |
| 08/26/1999 | WO1999029883A3 Targeting antigen-specific t cells for specific immunotherapy of autoimmune disease |
| 08/26/1999 | WO1999028475A9 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 08/26/1999 | WO1999027954A3 Mixed lipopeptide micelles for inducing an immune response |
| 08/26/1999 | WO1999024571A3 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
| 08/26/1999 | WO1999020774A3 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS |
| 08/26/1999 | WO1999006428A9 Tango-72 and tango-77 nucleic acid molecules and polypeptides |
| 08/26/1999 | WO1999004265A3 Cancer associated nucleic acids and polypeptides |